Big Pharma's Fight Against the Coronavirus Pandemic: Good News and Bad NewsThe Motley Fool • 03/19/20
Pfizer, GlaxoSmithKline, Johnson & Johnson Team Up on Once-Monthly HIV TreatmentThe Motley Fool • 03/10/20
GlaxoSmithKline Signs COVID-19 Collaboration Deal With Clover BiopharmaceuticalsThe Motley Fool • 02/24/20
FDA's Advisory Committee to Review Claims That GlaxoSmithKline's Trelegy Ellipta Reduces MortalityThe Motley Fool • 02/21/20
GlaxoSmithKline Signs Potential $600 Million-Plus Cancer Immunotherapy Research-Partnership DealThe Motley Fool • 02/20/20